Aimery Organosys Profile
Key Indicators
- Authorised Capital ₹ 0.70 M
- Paid Up Capital ₹ 0.61 M
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
About Aimery Organosys
Aimery Organosys Private Limited (AOPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 November 2012 and has a history of 12 years and three months. Its registered office is in Mumbai, Maharashtra.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.70 M and a paid-up capital of Rs 0.61 M, as per Ministry of Corporate Affairs (MCA) records.
Lokesh Agarwal, Mradula Agarwal, and Awanindra Singh serve as directors at the Company.
Company Details
- Location Mumbai, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233MH2012PTC237809
- Company No.
237809
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Nov 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Aimery Organosys Private Limited offer?
Aimery Organosys Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Antipyretic and Analgesic API.
Who are the key members and board of directors at Aimery Organosys?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lokesh Agarwal  | Director | 10-Nov-2012 | Current |
| Awanindra Singh | Director | 01-Apr-2017 | Current |
| Mradula Agarwal | Director | 10-Nov-2012 | Current |
Financial Performance of Aimery Organosys.
Aimery Organosys Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Aimery Organosys?
In 2017, Aimery Organosys had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aimery Global Tradelinks LlpLokesh Agarwal and Mradula Agarwal are mutual person
- Leechem India Private Limited
Lokesh Agarwal and Mradula Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aimery Organosys?
Unlock and access historical data on people associated with Aimery Organosys, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aimery Organosys, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aimery Organosys's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
